From Medscape Rheumatology

News from ACR 2012

November 09 - 14, 2012; Washington, DC

This coverage is not sanctioned by, nor a part of, the ACR.

Meeting Highlights at a Glance

Top News From ACR 2012: Slideshow
Highlights from the meeting include findings that some rheumatoid arthritis patients may be able to taper biologic therapy, ustekinumab eases psoriatic arthritis (PSUMMIT II trial), and a novel cathepsin K inhibitor builds bone in older osteoporotic women.

Conference News

Medscape Rheumatology©  WebMD, LLC

Perspectives

Prophylaxis, Treatment, and Foods to Avoid in Gout
Jonathan Kay, MD

Belimumab Revisited: How Has It Performed?
Jonathan Kay, MD; Ronald F. Van Vollenhoven, MD, PhD

Rheumatoid Arthritis: A New Class, a New Approval, a New Approach
Jonathan Kay, MD; Ronald F. Van Vollenhoven, MD, PhD

Tofacitinib Approved: Now How Do We Use It?
Jonathan Kay, MD